Study reports the first protein-based diagnostic signature to discriminate MIS-C from Kawasaki Disease and other common infections

Researchers explore the distinguishing features of MIS-C as compared to other inflammatory-infectious syndromes in children.

Adaptimmune nears second sarcoma approval as Phase II trial hits endpoints – Pharmaceutical Technology

The primary analysis of the IGNYTE-ESO trial comprises data from 64 patients with either synovial sarcoma or myxoid/round cell liposarcoma (MRCLS). Credit: Nadiia Lapshynska via Shutterstock. Adaptimmune’s

November 14, 2024

University Hospitals Taps Nuance to Improve Patient Engagement

by Jasmine Pennic 06/21/2023 Leave a Comment What You Should Know: Nuance Communications announced that Cleveland-based University Hospitals has chosen Nuance Patient Engagement Solutions to

June 21, 2023

Abbott and Medtronic Partner to Advance Diabetes Care

What You Should Know: – Abbott and Medtronic announced a groundbreaking partnership to develop an integrated continuous glucose monitoring (CGM) system designed to seamlessly work

August 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.